Related Experiment Video
Updated: Jul 8, 2025
07:50
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
182
PRISMA-the 100 most-cited articles on chondrosarcoma recurrence: A bibliometric analysis
Baoquan Xin1,2, Guangjian Bai1,2, Pan Gao2,3
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Medicine
|December 20, 2023
Summary
This study analyzed the top 100 cited articles on chondrosarcoma (CHS) recurrence. Research is citation-rich but focuses on treatments, highlighting a need for mechanistic exploration for future breakthroughs.
Area of Science:
- Orthopedics
- Oncology
- Bibliometrics
Background:
- Chondrosarcoma (CHS) is the most common adult malignant bone tumor and is prone to recurrence.
- Understanding research trends in CHS recurrence is crucial for advancing treatment strategies.
Purpose of the Study:
- To identify and analyze the top 100 most-cited articles on chondrosarcoma recurrence.
- To provide researchers with a concise overview of the field's focus and progress.
Main Methods:
- Bibliometric analysis of 305 articles on CHS recurrence published between 2013 and 2022.
- Selection of the top 100 most-cited articles based on Web of Science data.
- Analysis of publication year, journal, country, institution, and keywords.
Main Results:
- The most cited article received 224 citations.
- Key journals include 'Clinical Orthopaedics Related Research'; leading institutions are Fudan University, University of Texas System, and Royal Orthopaedic Hospital.
- China and the USA are the most represented countries; 2018 was the most productive year.
Conclusions:
- Research on CHS recurrence is highly cited.
- Current research emphasizes treatment over mechanistic understanding.
- Future breakthroughs require deeper exploration of underlying mechanisms.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:21Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K